SmartMom: Teaching by Texting to Promote Health Behaviours in Pregnancy - Trial NCT05793944
Access comprehensive clinical trial information for NCT05793944 through Pure Global AI's free database. This phase not specified trial is sponsored by University of British Columbia and is currently Not yet recruiting. The study focuses on Pregnancy. Target enrollment is 3078 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of British Columbia
Timeline & Enrollment
N/A
Jun 01, 2023
Feb 01, 2026
Primary Outcome
Change in weight during pregnancy,Attendance at prenatal care visits through pregnancy
Summary
The goal of this randomized clinical trial is to evaluate the effectiveness of SmartMom, a
 text messaging-based mobile health program for prenatal education. The main questions are to
 determine if healthy pregnant people receiving SmartMom messages that promote health
 behaviours in pregnancy versus messages that don't provoke behaviour change have improvement
 in:
 
 1. knowledge about healthy pregnancy and birth
 
 2. standardized measures of depression, anxiety, and fear of childbirth
 
 3. adoption of positive health behaviours in pregnancy
 
 4. maternal, fetal, and newborn outcomes
 
 Participants in the intervention group will receive three evidence-based text messages per
 week, plus optional supplemental messages on topics relevant to them, throughout pregnancy.
 
 The control group will receive general interest messages on pregnancy-related topics that are
 not promoting behaviour change.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05793944
Non-Device Trial